66. IgA nephropathy
199 clinical trials,   214 drugs   (DrugBank: 57 drugs),   32 drug target genes,   128 drug target pathways
Searched query = "IgA nephropathy", "IgA nephritis", "Berger disease", "IgA-IgG nephropathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04525729 (ClinicalTrials.gov) | July 1, 2020 | 17/8/2020 | Rituximab and RASi in Patients With IgAN | A Multicentre, Randomized, Controlled Study of Rituximab in Treatment of Primary IgA Nephropathy | IgA Nephropathy | Drug: Rituximab;Drug: RAS 2410 | CHENNAN | NULL | Recruiting | 18 Years | 75 Years | All | 116 | Phase 4 | China |